ミニメド・グループ
MiniMed Group, Inc. Common Stock
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 0.00 | $843M | -$90M |
| 2026 Q4 | -0.68 | $837M | -$226M |
| 2026 Q4 | -0.68 | $837M | -$226M |
| 2026 Q3 | -0.42 | $790M | $13M |
| 2025 Q2 | 0.00 | $752M | -$13M |
| 2025 Q4 | 0.00 | $724M | $26M |